Zkusit zdarma
Arcellx, Inc.

Arcellx, Inc.

ACLX
Cena:
$ 115.07
+0.02 (0.02%)
Valuace
70
Růst
0
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel

Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel

8:45 28-04-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the succe...

Are Medical Stocks Lagging Arcellx (ACLX) This Year?

Are Medical Stocks Lagging Arcellx (ACLX) This Year?

10:45 27-04-2026

Here is how Arcellx, Inc. (ACLX) and Astellas Pharma Inc. (ALPMY) have performed compared to their s...

Arcellx, Inc. (NASDAQ:ACLX) Given Consensus Recommendation of “Hold” by Analysts

Arcellx, Inc. (NASDAQ:ACLX) Given Consensus Recommendation of “Hold” by Analysts

2:12 24-04-2026

Arcellx, Inc. (NASDAQ: ACLX - Get Free Report) has been given an average rating of "Hold" by the nin...

Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer

Gilead Receives All Required Regulatory Approvals for the Acquisition of Arcellx and Extends Tender Offer

8:30 17-04-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) announced today that all ...

Banque Pictet & Cie SA Acquires Shares of 5,109 Arcellx, Inc. $ACLX

Banque Pictet & Cie SA Acquires Shares of 5,109 Arcellx, Inc. $ACLX

3:44 04-04-2026

Banque Pictet and Cie SA bought a new stake in shares of Arcellx, Inc. (NASDAQ: ACLX) in the fourth ...

Gilead Extends Tender Offer to Acquire Arcellx

Gilead Extends Tender Offer to Acquire Arcellx

16:13 01-04-2026

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today extended the expira...

Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?

Are ACLX, MASI, FONR Obtaining Fair Deals for their Shareholders?

14:02 19-03-2026

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan...

Halper Sadeh LLC is Investigating Whether KW, ACLX are Obtaining Fair Deals for their Shareholders

Halper Sadeh LLC is Investigating Whether KW, ACLX are Obtaining Fair Deals for their Shareholders

8:00 19-03-2026

NEW YORK, March 19, 2026 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is inves...

This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal

This $64 Million Biotech Exit Seemingly Missed a 77% One-Day Surge on Gilead Takeover Deal

19:13 16-03-2026

Cormorant Asset Management sold 775,000 Arcellx shares in the fourth quarter. The fund's quarter-end...

Bamco Inc. NY Has $45.17 Million Stake in Arcellx, Inc. $ACLX

Bamco Inc. NY Has $45.17 Million Stake in Arcellx, Inc. $ACLX

4:22 16-03-2026

Bamco Inc. NY lifted its holdings in Arcellx, Inc. (NASDAQ: ACLX) by 6.2% during the undefined quart...

Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX

Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX

16:06 13-03-2026

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., ...

Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise?

Will GILD's Move to Acquire ACLX Boost Its Cell Therapy Franchise?

11:11 13-03-2026

Gilead plans a $7.8B Arcellx acquisition as cell therapy sales decline, seeking full control of anit...

Are ACLX, DBRG, AVO, CVGW Obtaining Fair Deals for their Shareholders?

Are ACLX, DBRG, AVO, CVGW Obtaining Fair Deals for their Shareholders?

14:30 09-03-2026

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan...

The M&A Class Action Firm Encourages $hareholders to Contact Monteverde Concerning the Merger—ACLX, VRE, EHAB, and CECO

The M&A Class Action Firm Encourages $hareholders to Contact Monteverde Concerning the Merger—ACLX, VRE, EHAB, and CECO

12:35 05-03-2026

NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Class Action Attorney Juan Monteverde with Monteverde a...

Arcellx, Inc. (NASDAQ:ACLX) Receives Average Rating of “Hold” from Analysts

Arcellx, Inc. (NASDAQ:ACLX) Receives Average Rating of “Hold” from Analysts

1:26 05-03-2026

Arcellx, Inc. (NASDAQ: ACLX - Get Free Report) has earned an average recommendation of "Hold" from t...

Halper Sadeh LLC is Investigating Whether ACLX, VRE, EHAB are Obtaining Fair Deals for their Shareholders

Halper Sadeh LLC is Investigating Whether ACLX, VRE, EHAB are Obtaining Fair Deals for their Shareholders

14:46 04-03-2026

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders....

Top 2 Health Care Stocks That May Crash This Quarter

Top 2 Health Care Stocks That May Crash This Quarter

8:55 04-03-2026

As of March 4, 2026, two stocks in the health care sector could be flashing a real warning to invest...

Baron Health Care Fund Q4 2025 Contributors And Detractors

Baron Health Care Fund Q4 2025 Contributors And Detractors

10:18 03-03-2026

Eli Lilly and Company's shares rose during the quarter as Zepbound's obesity launch continued to gai...

Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX

Arcellx Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Arcellx, Inc. - ACLX

19:21 23-02-2026

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., ...

Are ACLX, VRE, UHG, EHAB Obtaining Fair Deals for their Shareholders?

Are ACLX, VRE, UHG, EHAB Obtaining Fair Deals for their Shareholders?

17:22 23-02-2026

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following compan...

close

ARCELLX ANNOUNCES LATE-BREAKING PRESENTATION AT TANDEM DEMONSTRATING UNIQUE, HIGH TARGET-SPECIFICITY OF ANITO-CEL'S D-DOMAIN BINDER

04-02-2026
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY FOCUSED...
Více zde

ARCELLX TO ADVANCE THE CONVERSATION ON ITS PLATFORM AND THE IMPORTANCE OF EARLY CAR T ACCESS FOR PATIENTS WITH MULTIPLE MYELOMA DURING THE 2026 TANDEM MEETINGS

21-01-2026
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX ANNOUNCES NEW POSITIVE DATA FOR ITS IMMAGINE-1 STUDY IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

06-12-2025
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX TO HOST INVESTOR RELATIONS EVENT DURING THE 67TH ASH ANNUAL MEETING AND EXPOSITION

18-11-2025
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX PROVIDES THIRD QUARTER 2025 FINANCIAL RESULTS

05-11-2025
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX TO PARTICIPATE AT THE 2025 MORGAN STANLEY GLOBAL HEALTHCARE CONFERENCE

03-09-2025
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX ANNOUNCES ITS PARTICIPATION AT TD COWEN'S 6TH ANNUAL ONCOLOGY INNOVATION SUMMIT AND ITS INVESTOR EVENT DURING EHA2025

21-05-2025
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX ANNOUNCES NEW POSITIVE DATA FOR ITS IMMAGINE-1 STUDY IN PATIENTS WITH RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA

14-05-2025
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX APPOINTS ANDREW GALLIGAN AND KRISTIN MYERS TO ITS BOARD OF DIRECTORS

20-03-2025
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX CMO DISCUSSES NOVEL INVESTIGATIONAL CAR-T THERAPY DURING MULTIPLE MYELOMA AWARENESS MONTH

18-03-2025
NEW YORK, MARCH 18, 2025 (GLOBE NEWSWIRE) -- TODAY'S MARKETPLACE (TMP) IS PROUD TO ANNOUNCE A FEATUR...
Více zde

ARCELLX TO PARTICIPATE AT THE TD COWEN 45TH ANNUAL HEALTH CARE CONFERENCE

26-02-2025
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX ANNOUNCES NEW POSITIVE DATA FOR ITS IMMAGINE-1 STUDY IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA TO BE PRESENTED DURING AN ORAL PRESENTATION AT THE 66TH ASH ANNUAL MEETING AND EXPOSITION

08-12-2024
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

KITE AND ARCELLX CONTINUE MOMENTUM WITH ADVANCES IN ANITO-CEL MULTIPLE MYELOMA PROGRAM

09-05-2024
REDWOOD CITY, CALIF. & SANTA MONICA, CALIF.--(BUSINESS WIRE)--KITE, A GILEAD COMPANY (NASDAQ: GILD),...
Více zde

ARCELLX TO PARTICIPATE IN THE 23RD ANNUAL NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

04-04-2024
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX TO PARTICIPATE AT THE H.C. WAINWRIGHT 2ND ANNUAL CELL THERAPY VIRTUAL CONFERENCE

20-03-2024
REDWOOD CITY, CALIF.--(BUSINESS WIRE)--ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY COMPANY REIMAGI...
Více zde

ARCELLX TO PARTICIPATE AT THE TD COWEN 44TH ANNUAL HEALTH CARE CONFERENCE

29-02-2024
REDWOOD CITY, CALIF. , FEB. 29, 2024 /PRNEWSWIRE/ -- ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY C...
Více zde

ARCELLX PROVIDES FOURTH QUARTER AND YEAR-END 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

28-02-2024
-- EXPANDED STRATEGIC PARTNERSHIP WITH KITE -- -- PRESENTED CONTINUED ROBUST LONG-TERM RESPONSES FRO...
Více zde

ARCELLX ANNOUNCES CONTINUED ROBUST LONG-TERM RESPONSES FROM ITS CART-DDBCMA (ANITO-CEL) PHASE 1 EXPANSION TRIAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AT ASH

08-12-2023
-- MEDIAN DURATION OF RESPONSE, PROGRESSION FREE SURVIVAL, AND OVERALL SURVIVAL RATE NOT REACHED WIT...
Více zde

ARCELLX AND KITE ANNOUNCE EXPANSION IN STRATEGIC PARTNERSHIP

15-11-2023
-- ARCELLX TO RECEIVE $200M EQUITY INVESTMENT AT $61.68 PER SHARE AND AN $85 MILLION UPFRONT CASH PA...
Více zde

ARCELLX PROVIDES THIRD QUARTER 2023 FINANCIAL RESULTS AND BUSINESS HIGHLIGHTS

13-11-2023
-- RECENTLY RELEASED ASH ABSTRACT FOR THE COMPANY'S PHASE 1 CART-DDBCMA TRIAL DEMONSTRATED THAT MED...
Více zde

ARCELLX ANNOUNCES ORAL PRESENTATION FOR ITS CART-DDBCMA PHASE 1 TRIAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AT THE 65TH ASH ANNUAL MEETING AND EXPOSITION

02-11-2023
-- ABSTRACT RELEASED TODAY IS FROM A JUNE 2, 2023 DATA CUT -- -- MEDIAN DURATION OF RESPONSE, PROGRE...
Více zde

ARCELLX TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES

26-10-2023
REDWOOD CITY, CALIF. , OCT. 26, 2023 /PRNEWSWIRE/ -- ARCELLX, INC. (NASDAQ: ACLX), A BIOTECHNOLOGY C...
Více zde

SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ARCELLX, INC. - ACLX

17-07-2023
NEW YORK , JULY 17, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTO...
Více zde

SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ARCELLX, INC. - ACLX

12-07-2023
NEW YORK , JULY 12, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ARCELLX, INC. - ACLX

03-07-2023
NEW YORK , JULY 3, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTORS...
Více zde

SHAREHOLDER ALERT: POMERANTZ LAW FIRM INVESTIGATES CLAIMS ON BEHALF OF INVESTORS OF ARCELLX, INC. - ACLX

23-06-2023
NEW YORK , JUNE 23, 2023 /PRNEWSWIRE/ -- POMERANTZ LLP IS INVESTIGATING CLAIMS ON BEHALF OF INVESTOR...
Více zde

ARCELLX ANNOUNCES CLINICAL HOLD FOR ITS IMMAGINE-1 PHASE 2 CLINICAL PROGRAM

19-06-2023
-- FDA HAS PROVIDED CLEARANCE TO THE COMPANY TO CONTINUE DOSING PATIENTS WHO HAVE ALREADY UNDERGONE ...
Více zde

KITE AND ARCELLX CLOSE AGREEMENT TO CO-DEVELOP AND CO-COMMERCIALIZE LATE-STAGE CLINICAL CART-DDBCMA IN MULTIPLE MYELOMA

30-01-2023
SANTA MONICA, CALIF. & REDWOOD CITY, CALIF.--( BUSINESS WIRE )--KITE, A GILEAD COMPANY (NASDAQ: GILD...
Více zde

KITE AND ARCELLX ANNOUNCE STRATEGIC COLLABORATION TO CO-DEVELOP AND CO-COMMERCIALIZE LATE-STAGE CLINICAL CART-DDBCMA IN MULTIPLE MYELOMA

09-12-2022
SANTA MONICA, CALIF. & REDWOOD CITY, CALIF.--( BUSINESS WIRE )--KITE, A GILEAD COMPANY (NASDAQ: GILD...
Více zde

ARCELLX AND KITE ANNOUNCE STRATEGIC COLLABORATION TO CO-DEVELOP AND CO-COMMERCIALIZE LATE-STAGE CLINICAL CART-DDBCMA IN MULTIPLE MYELOMA

09-12-2022
-- COLLABORATION LEVERAGES EXPERTISE ACROSS BOTH COMPANIES, INCLUDING KITE'S GLOBAL CELL THERAPY LEA...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-12-08 00:00:008-KStáhnout
2025-11-05 00:00:008-KStáhnout
2025-11-05 00:00:0010-QStáhnout
2025-08-07 01:00:008-KStáhnout
2025-08-07 01:00:0010-QStáhnout
2025-08-07 00:00:008-KStáhnout
2025-08-07 00:00:0010-QStáhnout
2025-05-28 01:00:008-KStáhnout
2025-05-28 00:00:008-KStáhnout
2025-05-14 01:00:008-KStáhnout
2025-05-14 00:00:008-KStáhnout
2025-05-08 01:00:008-KStáhnout
2025-05-08 01:00:0010-QStáhnout
2025-05-08 00:00:008-KStáhnout
2025-05-08 00:00:0010-QStáhnout
2025-03-20 00:00:008-KStáhnout
2025-03-19 23:00:008-KStáhnout
2025-02-27 00:00:008-KStáhnout
2025-02-27 00:00:0010-KStáhnout
2025-02-26 23:00:008-KStáhnout
2025-02-26 23:00:0010-KStáhnout
2024-12-12 00:00:008-KStáhnout
2024-12-11 23:00:008-KStáhnout
2024-12-09 00:00:008-KStáhnout
2024-12-08 23:00:008-KStáhnout
2024-11-07 00:00:008-KStáhnout
2024-11-07 00:00:0010-QStáhnout
2024-11-06 23:00:008-KStáhnout
2024-11-06 23:00:0010-QStáhnout
2024-11-05 00:00:008-KStáhnout
2024-11-04 23:00:008-KStáhnout
2024-08-08 01:00:008-KStáhnout
2024-08-08 01:00:0010-QStáhnout
2024-08-08 00:00:008-KStáhnout
2024-08-08 00:00:0010-QStáhnout
2024-05-29 01:00:008-KStáhnout
2024-05-29 00:00:008-KStáhnout
2024-05-09 01:00:008-KStáhnout
2024-05-09 01:00:0010-QStáhnout
2024-05-09 00:00:008-KStáhnout
2024-05-09 00:00:0010-QStáhnout
2024-03-14 00:00:008-KStáhnout
2024-03-13 23:00:008-KStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-28 00:00:0010-KStáhnout
2024-02-27 23:00:008-KStáhnout
2024-02-27 23:00:0010-KStáhnout
2024-01-31 00:00:008-KStáhnout
2024-01-30 23:00:008-KStáhnout
2023-12-28 00:00:008-KStáhnout
2023-12-27 23:00:008-KStáhnout
2023-12-12 00:00:008-KStáhnout
2023-12-11 23:00:008-KStáhnout
2023-12-08 00:00:008-KStáhnout
2023-12-07 23:00:008-KStáhnout
2023-11-15 00:00:008-KStáhnout
2023-11-14 23:00:008-KStáhnout
2023-11-13 00:00:008-KStáhnout
2023-11-13 00:00:0010-QStáhnout
2023-11-12 23:00:008-KStáhnout
2023-11-12 23:00:0010-QStáhnout
2023-11-02 00:00:008-KStáhnout
2023-11-01 23:00:008-KStáhnout
2023-08-14 01:00:008-KStáhnout
2023-08-14 01:00:0010-QStáhnout
2023-08-14 00:00:008-KStáhnout
2023-08-14 00:00:0010-QStáhnout
2023-06-20 01:00:008-KStáhnout
2023-06-20 00:00:008-KStáhnout
2023-06-14 01:00:008-KStáhnout
2023-06-14 00:00:008-KStáhnout
2023-05-08 01:00:008-KStáhnout
2023-05-08 01:00:0010-QStáhnout
2023-05-08 00:00:008-KStáhnout
2023-05-08 00:00:0010-QStáhnout
2023-03-29 01:00:008-KStáhnout
2023-03-29 01:00:0010-KStáhnout
2023-03-29 00:00:008-KStáhnout
2023-03-29 00:00:0010-KStáhnout
2023-01-30 00:00:008-KStáhnout
2023-01-29 23:00:008-KStáhnout
2022-12-16 00:00:008-KStáhnout
2022-12-15 23:00:008-KStáhnout
2022-12-12 00:00:008-KStáhnout
2022-12-11 23:00:008-KStáhnout
2022-12-09 00:00:008-KStáhnout
2022-12-08 23:00:008-KStáhnout
2022-11-14 00:00:008-KStáhnout
2022-11-14 00:00:0010-QStáhnout
2022-11-13 23:00:008-KStáhnout
2022-11-13 23:00:0010-QStáhnout
2022-11-09 00:00:008-KStáhnout
2022-11-08 23:00:008-KStáhnout
2022-08-15 01:00:008-KStáhnout
2022-08-15 01:00:0010-QStáhnout
2022-08-15 00:00:008-KStáhnout
2022-08-15 00:00:0010-QStáhnout
2022-06-21 01:00:008-KStáhnout
2022-06-21 00:00:008-KStáhnout
2022-05-23 01:00:008-KStáhnout
2022-05-23 00:00:008-KStáhnout
2022-05-16 01:00:008-KStáhnout
2022-05-16 00:00:008-KStáhnout
2022-05-12 01:00:008-KStáhnout
2022-05-12 01:00:0010-QStáhnout
2022-05-12 00:00:008-KStáhnout
2022-05-12 00:00:0010-QStáhnout
2022-03-24 00:00:008-KStáhnout
2022-03-24 00:00:0010-KStáhnout
2022-03-23 23:00:008-KStáhnout
2022-03-23 23:00:0010-KStáhnout
2022-02-17 00:00:008-KStáhnout
2022-02-16 23:00:008-KStáhnout
2022-02-09 00:00:008-KStáhnout
2022-02-08 23:00:008-KStáhnout
preloader